Uttam Sowmya
The College of Alabama at Birmingham and Southern Exploration have found another medication applicant that offers a serious step forward in the treatment for diabetes.
Tried on separated human and mouse pancreatic islets, mouse and rodent cell societies and creature models of both Sort 1 and Type 2 diabetes, the test tranquilize fundamentally improved four impeding attributes of diabetes: hyperglycemia, known as high glucose; hyperglucagonemia, rise in the hormone glucagon that neutralizes the impacts of insulin, advances glucose creation and expands blood glucose; extreme creation of glucose by the liver; and greasy liver, known as hepatic steatosis.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 